Pharmacogenetic Markers of Favipiravir Safety in COVID-19 Treatment
The aim of the study was to evaluate the associations of different variants of AOX1 and CYP1A2 genes with safety parameters of favipiravir therapy in patients with COVID-19. Material and Methods. The study included 86 patients hospitalized at Moscow Clinical Hospital No. 15 with a COVID-19 diagnosis...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Publishing House OKI"
2023-10-01
|
Series: | Антибиотики и Химиотерапия |
Subjects: | |
Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/1049 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!